Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 2, 2017, Pages E181-E190

  Engler, Jan Broder ^a   Kursawe, Nina ^a   Solano, María Emilia ^a   Patas, Kostas ^a   Wehrmann, Sabine ^a   Heckmann, Nina ^a   Lühder, Fred ^b   Reichardt, Holger M ^b   Arck, Petra Clara ^a   Gold, Stefan M ^a,c   Friese, Manuel A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoimmunity; Multiple sclerosis; Pregnancy; Steroid hormones; Treg

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CRE RECOMBINASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; ESTROGEN RECEPTOR ALPHA; FETAL ANTIGEN; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; NORGESTREL; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN KINASE LCK; STEROID HORMONE; STEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; BINDING AFFINITY; CELL SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENE DELETION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REPRODUCTION; REPRODUCTIVE SUCCESS; ANIMAL; C57BL MOUSE; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; MICE, INBRED C57BL; PREGNANCY; PROGESTERONE; RECEPTORS, GLUCOCORTICOID; T-LYMPHOCYTES;

EID: 85009291797     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1617115114     Document Type: Article

References (66)

1. Arck PC, Hecher K (2013) Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 19(5):548-556.
2. Collins MK, Tay C-S, Erlebacher A (2009) Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest 119(7):2062-2073.
3. Blois SM, et al. (2007) A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13(12):1450-1457.
4. Nancy P, et al. (2012) Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336(6086):1317-1321.
5. Erlebacher A (2013) Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 13(1):23-33.
6. de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW (2008) Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective study. Arthritis Rheum 59(9):1241-1248.
7. Forger F, et al. (2008) Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 67(7):984-990.
8. Buchel E, Van Steenbergen W, Nevens F, Fevery J (2002) Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 97(12):3160-3165.
9. Vukusic S, et al.; Pregnancy in Multiple Sclerosis Group (2004) Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain 127(Pt 6): 1353-1360.
10. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T; Pregnancy in Multiple Sclerosis Group (1998) Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339(5):285-291.
11. Finkelsztejn A, Brooks JBB, Paschoal FM, Jr, Fragoso YD (2011)What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and metaanalysis of the literature. BJOG 118(7):790-797.
12. Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15(9):545-558.
13. Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L (2002) Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: Evidence for a suppressive pregnancy-related serum factor. J Immunol 169(2):1084-1091.
14. Gatson NN, et al. (2011) Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol 230(1-2):105-113.
15. McClain MA, et al. (2007) Pregnancy suppresses experimental autoimmune enceph-alomyelitis through immunoregulatory cytokine production. J Immunol 179(12): 8146-8152.
16. Voskuhl RR, Palaszynski K (2001) Sex hormones in experimental autoimmune en-cephalomyelitis: Implications for multiple sclerosis. Neuroscientist 7(3):258-270.
17. Gold SM, Voskuhl RR (2016) Pregnancy and multiple sclerosis: From molecular mechanisms to clinical application. Semin Immunopathol 38(6):709-718.
18. Aluvihare VR, Kallikourdis M, Betz AG (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5(3):266-271.
19. Zenclussen AC, et al. (2006) Regulatory T cells induce a privileged tolerant microen-vironment at the fetal-maternal interface. Eur J Immunol 36(1):82-94.
20. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6(4):345-352.
21. Patas K, Engler JB, Friese MA, Gold SM (2013) Pregnancy and multiple sclerosis: Feto-maternal immune cross talk and its implications for disease activity. J Reprod Immunol 97(1):140-146.
22. Rowe JH, Ertelt JM, Xin L, Way SS (2012) Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490(7418):102-106.
23. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS (2011) Foxp3(+) regulatoryTcell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 10(1):54-64.
24. Mao G, et al. (2010) Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology 151(11): 5477-5488.
25. Lee JH, Ulrich B, Cho J, Park J, Kim CH (2011) Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol 187(4):1778-1787.
26. Wildin RS, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endo-crinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18-20.
27. Bennett CL, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1): 20-21.
28. Humrich JY, et al. (2010) Homeostatic imbalance of regulatory and effectorT cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci USA 107(1):204-209.
29. Engler JB, et al. (2011) Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus. Ann Rheum Dis 70(12):2176-2183.
30. Nie H, et al. (2013) Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-a in rheumatoid arthritis. Nat Med 19(3):322-328.
31. Munoz-Suano A, Kallikourdis M, Sarris M, Betz AG (2012) Regulatory T cells protect from autoimmune arthritis during pregnancy. J Autoimmun 38(2-3):J103-J108.
32. Baca Jones C, et al. (2014) Regulatory T cells control diabetes without compromising acute anti-viral defense. Clin Immunol 153(2):298-307.
33. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional sup-pression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199(7):971-979.
34. Carbone F, et al. (2014) Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med 20(1):69-74.
35. Sellebjerg F, Krakauer M, Khademi M, Olsson T, S0rensen PS (2012) FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis. Clin Exp Immunol 170(2):149-155.
36. Huan J, et al. (2005) Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81(1):45-52.
37. Venken K, et al. (2008) Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced fre-quency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123(1):79-89.
38. Holinka CF, Tseng YC, Finch CE (1979) Reproductive aging in C57BL/6J mice: Plasma progesterone, viable embryos and resorption frequency throughout pregnancy. Biol Reprod 20(5):1201-1211.
39. Solano ME, et al. (2015) Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. J Clin Invest 125(4):1726-1738.
40. Yates MA, et al. (2010) Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 220(1-2): 136-139.
41. Ojasoo T, Doré JC, Gilbert J, Raynaud JP (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis. J Med Chem 31(6): 1160-1169.
42. Tronche F, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23(1):99-103.
43. Orban PC, Chui D, Marth JD (1992) Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89(15):6861-6865.
44. Baumann S, et al. (2005) Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 106(2):617-625.
45. John S, et al. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet 43(3):264-268.
46. van der Laan S, et al. (2008) Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J Neurochem 106(6):2515-2523.
47. Ayroldi E, et al. (2007) GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest 117(6):1605-1615.
48. Nikic I, et al. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17(4):495-499.
49. Schattling B, et al. (2012) TRPM4 cation channel mediates axonal and neuronal de-generation in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 18(12):1805-1811.
50. Kahn DA, Baltimore D (2010) Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci USA 107(20):9299-9304.
51. Robertson SA, et al. (2009) Seminal fluid drives expansion of the CD4+CD25+ T reg-ulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 80(5):1036-1045.
52. Moldenhauer LM, et al. (2009) Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 182(12):8080-8093.
53. Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH (2007) Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 117(5):1399-1411.
54. Heng TSP, Painter MW; Immunological Genome Project Consortium (2008) The Im-munological Genome Project: Networks of gene expression in immune cells. Nat Immunol 9(10):1091-1094.
55. Barlow SM, Morrison PJ, Sullivan FM (1973) Plasma corticosterone levels during pregnancy in the mouse. Br J Pharmacol 48(2):346P.
56. Lépine S, Sulpice J-C, Giraud F (2005) Signaling pathways involved in glucocorticoid-induced apoptosis of thymocytes. Crit Rev Immunol 25(4):263-288.
57. Hoffman-Goetz L, Fietsch CL (2002) Lymphocyte apoptosis in ovariectomized mice given progesterone and voluntary exercise. J Sports Med Phys Fitness 42(4):481-487.
58. Gold SM, et al. (2012) Dynamic development of glucocorticoid resistance during au-toimmune neuroinflammation. J Clin Endocrinol Metab 97(8):E1402-E1410.
59. Wüst S, et al. (2008) Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 180(12):8434-8443.
60. Schweingruber N, et al. (2014) Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses. Acta Neuropathol 127(5):713-729.
61. van den Brandt J, et al. (2007) Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses. Am J Pathol 170(3): 1041-1053.
62. Andersen KG, Nissen JK, Betz AG (2012) Comparative genomics reveals key gain-of-function events in Foxp3 during regulatory T cell evolution. Front Immunol 3:113.
63. Sicotte NL, et al. (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52(4):421-428.
64. Pozzilli C, et al. (2015) Oral contraceptives combined with interferon p in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2(4):e120.
65. Voskuhl RR, et al. (2016) Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15(1):35-46.
66. Lydon JP, et al. (1995) Mice lacking progesterone receptor exhibit pleiotropic re-productive abnormalities. Genes Dev 9(18):2266-2278.